ACCESS TO MEDICINES STRATEGIES OF THE NATIONAL CANCER CONTROL PROGRAMME IN CAMEROON

  • Vanina Doris Edo'o Department of public health, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon. Laboratory of Research in Anthropology and social Medicine, University of Yaounde I, Yaounde, Cameroon.
  • Etienne Atenguena Oncology unit, Yaounde General Hospital, Yaounde, Cameroon.
  • Marie Josiane Ntsama Essomba Geriatric unit, Yaounde Central Hospital, Yaounde, Cameroon.
  • Suh Nchang Abenwie Department of public health, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon. Laboratory of Research in Anthropology and social Medicine, University of Yaounde I, Yaounde, Cameroon.
  • Emmanuel Nnanga Nga Department of Galenic Pharmacy and Pharmaceutical Legislation, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon.
  • Jim Nemy Hervé Department of public health, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon. Laboratory of Research in Anthropology and social Medicine, University of Yaounde I, Yaounde, Cameroon.
  • Thérèse Mbezele Essomba Department of public health, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon. Laboratory of Research in Anthropology and social Medicine, University of Yaounde I, Yaounde, Cameroon.
  • Yaya Ahidjo Laboratory of Research in Anthropology and social Medicine, University of Yaounde I, Yaounde, Cameroon.
  • Paul Ndom National Cancer Control Programme, Cameroon.
  • Marie-José Essi Department of public health, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon. Laboratory of Research in Anthropology and social Medicine, University of Yaounde I, Yaounde, Cameroon.

Abstract

Objective: Access to cancer drugs is a public health concern in low and middle-income countries. In Cameroon, the National Cancer Control Programme (NCCP) faces various obstacles to ensure accessibility of cancer drugs. This research aims to analyse the strategies implemented by the NCCP to ensure drugs selection and supply chain management,and  obstacles encountered at the central level.


Methodology: A qualitative cross-sectional situational analysis was carried out at the NCCP and the National Essential Medicines Supply Central (NEMSC)in Yaounde. For this purpose, tape-recorded interviews were conducted with key informants using two interview guides. After transcription, the verbal data were kept in a textual corpus and rendered in verbatim. The content analysis was done manually on the basis of a dimension matrix. SPSS version 20 was used to determine descriptive parameters like frequencies and means.


Results: 47% of the drugs retained were part of the National list of essential medicines. The NEMSC ordered 13 princeps. Among these, 35% had generics on the market. In logistics chain management, drug needs estimation and supply planning were based on approximation. As there was no sure information trackability and coordination between actors, not ensured. Also, a monitoring and evaluation plan had not been put in place. Furthermore, the only source of funding was the Government through the annual budget line. Limited financial resources allocated to supply was the main bottle neck, due to the high cost of the therapies and the ever-increasing demand. This resulted in a long stock-out(up to 15 months) for all the drugs and complete unavailability for others, like morphine, despite its great palliative care demand.


Conclusion: There are many challenges around cancer drugs accessibility in Cameroon. Therefore it is an urgent need to strengthen drug provision services within the NCCP.


                    r113.gif


Peer Review History:


Received: 4 September 2021; Revised: 10 October; Accepted: 4 October, Available online: 15 November 2021


Academic Editor:  Dr. Ali Abdullah Al-yahawiorcid22.jpg, Al-Razi university, Department of Pharmacy, Yemen, alyahawipharm@yahoo.com


UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency. 


Received file:blue_23983.gif                Reviewer's Comments:download_logo_r_29189.gif


Average Peer review marks at initial stage: 5.5/10


Average Peer review marks at publication stage: 7.0/10


Reviewers:


orcid22.jpgDr. A.A. Mgbahurike, University of Port Harcourt, Nigeria, amaka_mgbahurike@yahoo.com


orcid22.jpgDr. Muhammad Zahid Iqbal, AIMST University, Malaysia, drmmziqbal@gmail.com


Similar Articles:


EVALUATION OF CURRENT SCENARIO OF CANCER DISEASE AT CHATTAGRAM IN BANGLADESH


TREATMENT OF PATIENTS WITH ADVANCED CANCER FOLLOWING CHEMOTHERAPY AND TRADITIONAL MEDICINE - LONG TERM FOLLOW UP OF 75 CASES

Keywords: Access to medicines strategies, Cameroon, drug access challenges, NCCP, supply chain management

Downloads

Download data is not yet available.
Comments

Statistics
77 Views | 118 Downloads
Dimension Citations
How to Cite
Edo’o, V. D., E. Atenguena, M. J. N. Essomba, S. N. Abenwie, E. N. Nga, J. N. Hervé, T. M. Essomba, Y. Ahidjo, P. Ndom, and M.-J. Essi. “ACCESS TO MEDICINES STRATEGIES OF THE NATIONAL CANCER CONTROL PROGRAMME IN CAMEROON”. Universal Journal of Pharmaceutical Research, Vol. 6, no. 5, Nov. 2021, doi:https://doi.org/10.22270/ujpr.v6i5.675.
Section
Research Articles

Most read articles by the same author(s)